Dose intensification of vedolizumab is not effective in inducing endoscopic response in Crohn's disease patients with endoscopic primary non-response

被引:0
|
作者
Oldenburg, L.
Baert, F.
Bossuyt, P.
Hoentjen, F.
Clasquin, E.
Molnar, T.
Loewenberg, M.
Vermeire, S.
D'Haens, G.
机构
[1] Univ Amsterdam, Med Ctr, Gastroenterol, Amsterdam, Netherlands
[2] AZ Delta, Gastroenterol, Roeselare, Belgium
[3] Imelda Gen Hosp, Gastroenterol, Bonheiden, Belgium
[4] Univ Alberta, Gastroenterol, Edmonton, AB, Canada
[5] Univ Szeged, Internal Med, Szeged, Hungary
[6] Univ Hosp Leuven, Gastroenterol, Leuven, Belgium
来源
关键词
D O I
10.1093/ecco-jcc/jjae190.0009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OP09
引用
收藏
页码:i17 / i18
页数:2
相关论文
共 50 条
  • [1] Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease
    Lowenberg, Mark
    Vermeire, Severine
    Mostafavi, Nahid
    Hoentjen, Frank
    Franchimont, Denis
    Bossuyt, Peter
    Hindryckx, Pieter
    Rispens, Theo
    de Vries, Annick
    van der Woude, C. Janneke
    Berends, Sophie
    Ambarus, Carmen A.
    Mathot, Ron
    Clasquin, Esme
    Baert, Filip
    D'Haens, Geert
    GASTROENTEROLOGY, 2019, 157 (04) : 997 - +
  • [2] Nomogram to predict primary non-response to infliximab in patients with Crohn's disease: a multicenter study
    Ye, Xiao-Qi
    Cai, Jing
    Yu, Qiao
    Cao, Xiao-Cang
    Chen, Yan
    Rao, Mei-Xin
    Chen, Bai-Li
    He, Yao
    Zeng, Zhi-Rong
    Chen, Hao
    Lin, Yi-Mou
    Cao, Qian
    Chen, Min-Hu
    Zhang, Sheng-Hong
    GASTROENTEROLOGY REPORT, 2021, 9 (04): : 329 - 338
  • [3] The Value of Vedolizumab as Rescue Therapy in Moderate-Severe Crohn's Disease Patients with Adalimumab Non-response in the USA
    Erim, Daniel O.
    Mahendraratnam, Nirosha
    Okafor, Phillip N.
    Wheeler, Stephanie B.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (08): : 669 - 675
  • [4] Loss of Response to Vedolizumab and Ability of Dose Intensification to Restore Response in Patients With Crohn's Disease or Ulcerative Colitis: A Systematic Review and Meta-analysis
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    Argollo, Marjorie
    Pouillon, Lieven
    Peppas, Spyros
    Gonzalez-Lorenzo, Marien
    Lytras, Theodore
    Bonovas, Stefanos
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (05) : 838 - +
  • [5] Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease
    Danese, Silvio
    Sandborn, William J.
    Colombel, Jean-Frederic
    Vermeire, Severine
    Glover, Sarah C.
    Rimola, Jordi
    Siegelman, Jenifer
    Jones, Stephen
    Bornstein, Jeffrey D.
    Feagan, Brian G.
    GASTROENTEROLOGY, 2019, 157 (04) : 1007 - +
  • [6] Vedolizumab induces endoscopic and histological Remissions in Crohn's Disease
    Gappa, Birgit
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (12): : 1446 - +
  • [7] Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease
    Rutgeerts, Paul
    Gasink, Christopher
    Chan, Daphne
    Lang, Yinghua
    Pollack, Paul
    Colombel, Jean-Frederic
    Wolf, Douglas C.
    Jacobstein, Douglas
    Johanns, Jewel
    Szapary, Philippe
    Adedokun, Omoniyi J.
    Feagan, Brian G.
    Sandborn, William J.
    GASTROENTEROLOGY, 2018, 155 (04) : 1045 - 1058
  • [8] Metastatic Crohn's disease. Response to adalimumab dose intensification
    Lazaro Saez, Marta
    Hernandez Martinez, Alvaro
    Bendezu Garcia, Roger Alvaro
    Rodriguez Manrique, Marco Antonio
    Simon Lopez, Francisca
    Medina Estevez, Emilia
    Vega Saenz, Jose Luis
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2012, 35 (05): : 321 - 325
  • [9] Vedolizumab trough concentrations are associated with endoscopic response in patients with inflammatory bowel disease
    Chao, C. -Y.
    Restellini, S.
    Lemieux, C.
    Germain, P.
    Bitton, A.
    Lakatos, P. L.
    Wild, G.
    Seidman, E.
    Bessissow, T.
    Afif, W.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S367 - S368
  • [10] Endoscopic and Histologic Response and Remission in Inflammatory Bowel Disease Patients Initiating Vedolizumab
    Christensen, Britt
    Rubin, David T.
    Goeppinger, Sarah
    Colman, Ruben J.
    Yarur, Andres
    Hirsch, Ayal
    Bocheneck, Ashley
    Wichmann, Alana
    Sakuraba, Atsushi
    Cohen, Russell
    Siddiqui, Dania
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S783 - S784